BioMed Research International

Clinical Study

Lower Limb Core Scale: A New Application to Evaluate and Compare the Outcomes of Bone and Soft-Tissue Tumours Resection and Reconstruction

Table 6

Completed results of SF-36. Summary of measures: PF: physical functioning; RP: role limitation due to physical problems; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role limitation due to emotional problems; MH: mental health (score range: 0–100).
SF-36PFRPBPGHVTSFREMH
Total64,42 ± 9,0451,92 ± 15,664,04 ± 11,7864,04 ± 8,862,5 ± 9,0279,81 ± 9,9966,67 ± 14,9471,38 ± 7,47
Males72,86 ± 11,4664,29 ± 2475,43 ± 15,2667,71 ± 9,4767,14 ± 10,3985,71 ± 11,0578,57 ± 11,0276,29 ± 8,67
Females54,58 ± 13,5737,5 ± 19,5450,75 ± 17,1259,75 ± 16,2357,08 ± 15,9372,92 ± 17,852,78 ± 23,3965,67 ± 12,82
Age 5569 ± 21,353,33 ± 21,365,87 ± 17,9662,87 ± 17,9663,67 ± 10,9383,33 ± 10,5875,56 ± 16,6773,33 ± 9,32
Age 5558,18 ± 15,1450 ± 26,0861,55 ± 17,1965,64 ± 13,7660,91 ± 16,4975 ± 19,2454,55 ± 27,0368,73 ± 13,27
Proximal site60 ± 13,8647,73 ± 23,261,55 ± 16,8458,64 ± 15,2561,36 ± 13,2175 ± 16,1351,51 ± 24,467,27 ± 9,32
Distal site67,67 ± 13,0555 ± 23,4365,87 ± 18,268 ± 10,9963,33 ± 13,7683,33 ± 13,877,78 ± 18,4174,4 ± 12,09
Malignant lesion66,43 ± 7,8154,76 ± 15,6868,81 ± 11,9667,52 ± 7,366,43 ± 8,6483,33 ± 8,6468,25 ± 14,8874,1 ± 7,06
Benign lesion56 ± 20,2440 ± 23,6744 ± 11,4149,4 ± 19,146 ± 12,5665 ± 20,8660 ± 24,5960 ± 12,29
Recurrence69 ± 14,3460 ± 23,6755,8 ± 18,8471,8 ± 7,0362 ± 10,787,5 ± 1073,32 ± 20,6776,8 ± 10,05
Compliance64,64 ± 14,2348,21 ± 22,5162,64 ± 18,8268,23 ± 13,7271,79 ± 12,0388,39 ± 13,4471,43 ± 19,3877,43 ± 8,72
Group 166,88 ± 9,3150 ± 15,9551,25 ± 12,8864,38 ± 11,6678,13 ± 12,3978,13 ± 12,3975 ± 21,9773 ± 12,62
Group 263,33 ± 14,9452,78 ± 24,6967 ± 18,169,72 ± 11,9561,67 ± 14,2380,56 ± 15,9562,96 ± 22,3170,67 ± 10,56